Seeking Alpha
 

CVS Health Corporation (CVS)

- NYSE
  • Nov. 14, 2012, 8:16 PM
    Warren Buffett's Berkshire Hathaway discloses several changes to its portfolio, including a stake in Deere & Co. (DE) and selling off 5.3M shares of CVS Caremark (CVS). Firm also added to its existing investments in: Wells Fargo (WFC), Bank of New York Mellon Corp. (BK), General Motors (GM), DirecTV (DTV), DaVita (DVA), National Oilwell Varco (NOV) and Viacom (VIAB). It reduced stakes in: Johnson & Johnson (JNJ), Kraft Foods (KRFT), Lee Enterprises (LEE), Procter & Gamble (PG) and US Bancorp (USB). (13-F)
    | 3 Comments
  • Nov. 6, 2012, 10:07 AM
    CVS Caremark (CVS -0.8%) appears to have won over a lot of ex-Walgreen customers for good based on the drugstore operator's "blowout" Q3, notes CNBC's Jim Cramer (video). The company says it now expects to retain close to 60% of the new clients gained from the WAG-ESRX impasse after earlier estimates ranged lower.
    | Comment!
  • Nov. 6, 2012, 7:15 AM
    More on CVS Caremark (CVS): Retail pharmacy sales rose 4.3% with higher drug costs and the growth of the firm's Medicare Part D program contributing. The company raises and narrows its full-year guidance to $3.38-$3.41, from a prior range of $3.32-$3.38. (PR)
    | Comment!
  • Nov. 6, 2012, 7:03 AM
    CVS Caremark (CVS): Q3 EPS of $0.85 beats by $0.01. Revenue of $30.2B (+13.3% Y/Y) misses by $700M. (PR)
    | Comment!
  • Nov. 6, 2012, 12:05 AM
    Notable earnings before Tuesday’s open: AKRX, AMED, AMSC, AOL, CPN, CRIS, CRZO, CSC, CVC, CVS, DISCA, DISH, DNR, DTV, DWRE, EMR, EXPD, FOSL, FTR, FUN, GEL, HCN, HL, HPT, ISIS, KWK, MFA, NYX, ODP, OMX, OXF, POM, SCG, SRE, VVUS
    | 1 Comment
  • Nov. 5, 2012, 5:30 PM
    Notable earnings before Tuesday’s open: AKRX, AMED, AMSC, AOL, CPN, CRIS, CRZO, CSC, CVC, CVS, DISCA, DISH, DNR, DTV, DWRE, EMR, EXPD, FOSL, FTR, FUN, GEL, HCN, HL, HPT, ISIS, KWK, MFA, NYX, ODP, OMX, OXF, POM, SCG, SRE, VVUS
    | Comment!
  • Oct. 30, 2012, 11:38 AM
    Are Halloween candy sales at risk of being muted this year? As trick-or-treating gets delayed up and down the Eastern Seaboard the estimated $2.4B boom in candy sales in front of the holiday could come in light this year. Analysts say it won't be candy manufacturers that take the hit with stores already loaded up, but drugstore chains such as Walgreen (WAG), CVS Caremark (CVS), and Rite Aid (RAD) could see a disappointing holiday haul.
    | 1 Comment
  • Oct. 12, 2012, 7:14 AM
    CVS Caremark (CVS) is reportedly under investigation from federal officials looking into if the company violated Medicare laws. One of the allegations is that the company routinely refilled prescriptions without receiving prior approval from patients.
    | Comment!
  • Oct. 10, 2012, 10:29 AM
    Another tidbit from Wal-Mart's (WMT +2.8%) investor meeting (webcast): The company plans to have over 240 Neighborhood Market stores in place by the end of FY13, a significant pickup in the pace of growth for the small-sized supermarkets across the landscape. While posing an obvious threat to local and national grocery stores, the initiative could also effect pharmacy sales at Walgreen (WAG +0.1%), CVS Caremark (CVS +0.5%), and Rite Aid (RAD +0.4%) eventually.
    | 4 Comments
  • Sep. 19, 2012, 3:58 PM
    With the stock at an all-time high, CVS Caremark (CVS +0.8%) announces board approval of a new repurchase program for up to $6B worth of the company's shares. (PR)
    | 4 Comments
  • Sep. 12, 2012, 8:19 AM
    The DEA has withdrawn the controlled substance registrations of two CVS Caremark (CVS) pharmacies in Florida after some retail locations experienced sharply higher sales of the addictive prescription painkiller oxycodone. The DEA says CVS and its wholesale suppler Cardinal Health should have realized that the sales increase was a sign that the drugs were be resold in the black market.
    | 1 Comment
  • Sep. 4, 2012, 11:51 AM
    The FTC says checks will soon be in the mail for 13K Medicare beneficiaries who were charged too much by CVS Caremark (CVS -0.1%) at pharmacies. Though the monetary hit is relatively minor for CVS, it's in the middle of trying to hit its forecast of retaining at least 50% of the Walgreen customers who it snapped up during the Express Scripps impasse.
    | Comment!
  • Aug. 28, 2012, 12:30 PM
    A light flu season and increased competition over flu shots hit the bottom lines of drugstore chains last year, so this year they've decided to get an early jump to try to edge out retail players such as Wal-Mart and Target. CVS Caremark (CVS +0.5%), Walgreen (WAG -0.4%), and Rite Aid (RAD -0.5%) have all rolled out promotions aimed at getting customers into their pharmacies before the big boys catch the flu shot sale.
    | 1 Comment
  • Aug. 16, 2012, 9:39 AM
    Cantor Fitzgerald initiates both Walgreen (WAG -0.2%) and CVS Caremark (CVS +0.1%) with Buy ratings. While Walgreen is likely to benefit from the impact of acquisitions and generic drugs, CVS should see margin gains in retail and PBM operations this year, according to analyst Ajay Jain.
    | Comment!
  • Aug. 14, 2012, 6:15 PM
    Bespoke posts tables of sell-side analysts' most loved and most hated S&P 500 stocks. Eight boast at least 90% Buy ratings: SLM, A, SLB, CVS, ATI, COV, FLR, EMC. Take analyst recommendations with a fistful of salt but they're at least a sentiment indicator; note "the most loathed stock of all" - Sears (SHLD) - is up more than 70% YTD.
    | 5 Comments
  • Aug. 14, 2012, 8:25 AM
    The FTC yesterday said pharmaceutical companies are delaying generic competition by making patent settlement agreements in which they pledge not to launch their own copycat medicines. The FTC made the comments in a case involving CVS and Rite Aid (RAD), which are suing Pfizer (PFE) and TEVA for conspiring to keep generic versions of the antidepressant Effexor XR out of stores.
    | 4 Comments
CVS vs. ETF Alternatives
Company Description
CVS Health Corp CVS Health Corp iis an integrated pharmacy health care provider. The Company has three segments: Pharmacy Services, Retail Pharmacy and Corporate.
Sector: Services
Industry: Drug Stores
Country: United States